CDK11 antibody (AA 1-130)
Quick Overview for CDK11 antibody (AA 1-130) (ABIN6138305)
Target
See all CDK11 (CDK11B) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-130
-
Sequence
- MGDEKDSWKV KTLDEILQEK KRRKEQEEKA EIKRLKNSDD RDSKRDSLEE GELRDHRMEI TIRNSPYRRE DSMEDRGEED DSLAIKPPQQ MSRKEKAHHR KDEKRKEKRR HRSHSAEGGK HARVKEKERE
-
Cross-Reactivity
- Human, Mouse
-
Characteristics
- Polyclonal Antibodies
-
Purification
- Affinity purification
-
Immunogen
- Recombinant fusion protein containing a sequence corresponding to amino acids 1-130 of human CDK11B (NP_277021.2).
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB,1:500 - 1:2000,IF,1:50 - 1:200
-
Comment
-
HIGH QUALITY
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide,50 % glycerol, pH 7.3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze / thaw cycles.
-
-
- CDK11 (CDK11B) (Cyclin-Dependent Kinase 11B (CDK11B))
-
Alternative Name
- CDK11B
-
Background
- This gene encodes a member of the serine/threonine protein kinase family. Members of this kinase family are known to be essential for eukaryotic cell cycle control. Due to a segmental duplication, this gene shares very high sequence identity with a neighboring gene. These two genes are frequently deleted or altered in neuroblastoma. The protein kinase encoded by this gene can be cleaved by caspases and may play a role in cell apoptosis. Alternative splicing results in multiple transcript variants.,CDK11B,CDC2L1,CDK11,CDK11-p110,CDK11-p46,CDK11-p58,CLK-1,PITSLREA,PK58,p58,p58CDC2L1,p58CLK-1,Epigenetics & Nuclear Signaling,Cancer,Signal Transduction,Kinase,Cell Biology & Developmental Biology,Apoptosis,Cell Cycle,Cell cycle inhibitors,Cyclins,CDK11B
-
Molecular Weight
- 49-92 kDa
-
Gene ID
- 984
-
UniProt
- P21127
-
Pathways
- Regulation of Lipid Metabolism by PPARalpha, M Phase
Target
-